Characterisation of the anti-migratory activity of the 6-bromoindirubin-3’oxime (BIO) derivative VTIND42 in patient-derived GBM subpopulations

Authors: Samuel Peat, Anke Bruning-Richardson, Laurent Meijer, Sean Lawler, Valérie Thiéry, Ruth Morton

Published: 2019-10-12

DOI: 10.1093/neuonc/noz167.026

Source: Full article